Sidera Bio
4 known investors
Find your way into Sidera Bio
Sign up to see every warm intro you have to Sidera Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sidera Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sidera Bio is a biotechnology company using human genetics to develop new medicines for patients.
Investors · 4
Catalio Capital Management, LPlisted by Catalio Capital Management, LPNew York
How we know: Catalio Capital Management, LP's portfolio page · Not right? Tell us
ForbionreportedNaarden
How we know: funding news · Not right? Tell us
Novo HoldingsreportedCopenhagen · $1.1M – $54M
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ANov 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Sidera Bio do?
- Sidera Bio is a biotechnology company using human genetics to develop new medicines for patients.
- Who are Sidera Bio's investors?
- Sidera Bio's investors include Catalio Capital Management, LP, RA Capital, Forbion, Novo Holdings.

